Hypofractionated breast radiotherapy for one week versus three weeks (UK FAST-Forward): Ten-year efficacy and late normal tissue effects from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial and five-year efficacy in the randomised axillary sub-study

Cafferty, F; Bliss, J; Patel, J; Sydenham, M

Hypofractionated breast radiotherapy for one week versus three weeks (UK FAST-Forward): Ten-year efficacy and late normal tissue effects from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial and five-year efficacy in the randomised axillary sub-study

Files

FF 10year paper_LancOnc_Accepted_Feb2026.pdf (326.56 KB)

FF 10year paper_Tables and figs_LancOnc_Accepted_Feb2026.pdf (418.57 KB)

Embargo End Date

2026-06-17

ICR Authors

Cafferty, Fay Helen

Authors

Cafferty, F
Bliss, J
Patel, J
Sydenham, M

Document Type

Journal Article

Date Accepted

2026-03-17

Citation

The Lancet Oncology,

URI

https://repository.icr.ac.uk/handle/internal/7573

Rights

http://creativecommons.org/licenses/by/4.0/

Source Title

The Lancet Oncology

Publisher

Elsevier

ISSN

1470-2045

eISSN

1474-5488

Collections

Clinical Studies

Research Team

Clin Trials & Stats Unit

Full item page

Hypofractionated breast radiotherapy for one week versus three weeks (UK FAST-Forward): Ten-year efficacy and late normal tissue effects from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial and five-year efficacy in the randomised axillary sub-study

Files

Embargo End Date

ICR Authors

Authors

Document Type

Date

Date Accepted

Abstract

Citation

DOI

URI

Rights

Source Title

Publisher

ISSN

eISSN

Collections

Research Team

Notes